These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 16899348)
1. Successful treatment of eosinophilic otitis media using ramatroban: report of two cases. Wada T; Uemaetomari I; Murashita H; Tobita T; Tsuji S; Tabuchi K; Okubo H; Hara A Auris Nasus Larynx; 2006 Dec; 33(4):455-60. PubMed ID: 16899348 [TBL] [Abstract][Full Text] [Related]
2. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media. Iino Y; Kakizaki K; Katano H; Saigusa H; Kanegasaki S Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798 [TBL] [Abstract][Full Text] [Related]
3. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation. Uller L; Mathiesen JM; Alenmyr L; Korsgren M; Ulven T; Högberg T; Andersson G; Persson CG; Kostenis E Respir Res; 2007 Feb; 8(1):16. PubMed ID: 17328802 [TBL] [Abstract][Full Text] [Related]
4. An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. Sugimoto H; Shichijo M; Iino T; Manabe Y; Watanabe A; Shimazaki M; Gantner F; Bacon KB J Pharmacol Exp Ther; 2003 Apr; 305(1):347-52. PubMed ID: 12649388 [TBL] [Abstract][Full Text] [Related]
5. Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media. Iino Y; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Kanazawa H; Yoshida N Acta Otolaryngol; 2014 Apr; 134(4):366-72. PubMed ID: 24628335 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma. Iino Y; Nagamine H; Kakizaki K; Komiya T; Katano H; Saruya S; Kodera K Ann Allergy Asthma Immunol; 2006 Dec; 97(6):761-6. PubMed ID: 17201235 [TBL] [Abstract][Full Text] [Related]
7. A case of Churg-Strauss syndrome with refractory otitis media. Saka N; Seo T; Shimano K; Kashiba K; Mori T; Sakagami M Auris Nasus Larynx; 2009 Feb; 36(1):79-81. PubMed ID: 18384991 [TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of so called eosinophilic otitis media. Nagamine H; Iino Y; Kojima C; Miyazawa T; Iida T Auris Nasus Larynx; 2002 Jan; 29(1):19-28. PubMed ID: 11772486 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab. Suzaki I; Kimura Y; Tanaka A; Hirano K; Ishibashi A; Mizuyoshi T; Ando I; Kitajima T; Watanabe S; Hinohira Y; Kobayashi H Auris Nasus Larynx; 2019 Feb; 46(1):141-146. PubMed ID: 29909018 [TBL] [Abstract][Full Text] [Related]
12. Risk factors associated with severity of eosinophilic otitis media. Kanazawa H; Yoshida N; Yamamoto H; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Iino Y Auris Nasus Larynx; 2014 Dec; 41(6):513-7. PubMed ID: 25199747 [TBL] [Abstract][Full Text] [Related]
13. Ramatroban (BAY u 3405): a novel dual antagonist of TXA2 receptor and CRTh2, a newly identified prostaglandin D2 receptor. Ishizuka T; Matsui T; Okamoto Y; Ohta A; Shichijo M Cardiovasc Drug Rev; 2004; 22(2):71-90. PubMed ID: 15179446 [TBL] [Abstract][Full Text] [Related]
14. Eustachian tube function in patients with eosinophilic otitis media associated with bronchial asthma evaluated by sonotubometry. Iino Y; Kakizaki K; Saruya S; Katano H; Komiya T; Kodera K; Ohta K Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1109-14. PubMed ID: 17043260 [TBL] [Abstract][Full Text] [Related]
15. Effect of topical dexamethasone versus rimexolone on middle ear inflammation in experimental otitis media with effusion. Florea A; Zwart JE; Lee CW; Depew A; Park SK; Inman J; Wareham R; Johnson K; John E; Wall GM; Jung T Acta Otolaryngol; 2006 Sep; 126(9):910-5. PubMed ID: 16864486 [TBL] [Abstract][Full Text] [Related]
16. Complete Remission of Severe Eosinophilic Otitis Media With Dupilumab: A Case Report. van der Lans RJL; van Spronsen E; Fokkens WJ; Reitsma S Laryngoscope; 2021 Dec; 131(12):2649-2651. PubMed ID: 34216146 [TBL] [Abstract][Full Text] [Related]
17. A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils. Royer JF; Schratl P; Carrillo JJ; Jupp R; Barker J; Weyman-Jones C; Beri R; Sargent C; Schmidt JA; Lang-Loidolt D; Heinemann A Eur J Clin Invest; 2008 Sep; 38(9):663-71. PubMed ID: 18837743 [TBL] [Abstract][Full Text] [Related]
18. Tube associated otorrhea in children with recurrent acute otitis media; results of a prospective randomized study on bacteriology and topical treatment with or without systemic antibiotics. Granath A; Rynnel-Dagöö B; Backheden M; Lindberg K Int J Pediatr Otorhinolaryngol; 2008 Aug; 72(8):1225-33. PubMed ID: 18565598 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of corticosteroids in otitis media with effusion: an experimental study. Yaman H; Ozturk K; Uyar Y; Gurbilek M J Laryngol Otol; 2008 Jan; 122(1):25-30. PubMed ID: 17445334 [TBL] [Abstract][Full Text] [Related]